Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis.
Omaña-Guzmán I, Rosas-Diaz M, Martínez-López YE, Perez-Navarro LM, Diaz-Badillo A, Alanis A, Bustamante A, Castillo-Ruiz O, Del Toro-Cisneros N, Esquivel-Hernandez DA, Garcia-Villalobos G, Garibay-Nieto N, Garcia-Oropesa EM, Hernandez-Martinez JC, Lopez-Sosa EB, Maldonado C, Martinez D, Membreno J, Moctezuma-Chavez OO, Munguia-Cisneros CX, Nava-González EJ, Perales-Torres AL, Pérez-García A, Rivera-Marrero H, Valdez A, Vázquez-Chávez AA, Ramirez-Pfeiffer C, Carter KV, Tapia B, Vela L, Lopez-Alvarenga JC.
Omaña-Guzmán I, et al. Among authors: carter kv.
BMC Med. 2024 Nov 21;22(1):548. doi: 10.1186/s12916-024-03744-x.
BMC Med. 2024.
PMID: 39574069
Free PMC article.